Showing 2281-2290 of 2839 results for "".
- Allergan Aesthetics Submits BLA for TrenibotulinumtoxinE for Glabellar Lineshttps://modernaesthetics.com/news/abbvie-submits-bla-for-trenibotulinumtoxine-for-glabellar-lines/2475351/Allergan Aesthetics, an AbbVie Company, has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for trenibotulinumtoxinE (TrenibotE), seeking approval for the treatment of moderate to severe glabellar lines. TrenibotE, a serotype E botulinum toxin
- Research Firm Executive Explains Optimistic Market Forecasthttps://modernaesthetics.com/news/research-firm-executive-explains-optimistic-market-forecast/2475344/The research firm Clarivate projected the global aesthetics market to reach a value of €22.9 billion by 2028, growing at a compound annual growth rate (CAGR) of nearly 8%. This growth, Clarivate said, is driven by trends such as the shift toward natural-looking treatments, the rise of combination
- Actress Shay Mitchell to Serve as Global Brand Ambassador for OGXhttps://modernaesthetics.com/news/actress-shay-mitchell-to-serve-as-global-brand-ambassador-for-ogx/2475343/Kenvue Inc. introduced actress and entrepreneur Shay Mitchell as the global brand ambassador for OGX®, stepping in as the face of the brand’s Fixer character in their new campaign. "My life is busy, and my hair goes through a lot," Mitchell said in a press release. "OGX products keep my ha
- Advalight to Directly Manage Its Sales Operations, Introduce New Laserhttps://modernaesthetics.com/news/advalight-to-directly-manage-its-sales-operations-introduce-new-laser/2475342/Danish laser company Advalight will directly manage its sales operations moving forward, the president of the company’s US subsidiary said on LinkedIn. Travis Mahan, president of Advalight Corp and executive vice president of global sales for Advalight, said the move is “to better align wi
- The Aesthetic Foundation Appoints Dr. Patricia A. McGuire New Presidenthttps://modernaesthetics.com/news/the-aesthetic-foundation-appoints-dr-patricia-a-mcguire-new-president/2475340/The Aesthetic Foundation recently announced the appointment of Patricia A. McGuire, MD, as its new president. Dr. McGuire is a board-certified plastic surgeon and breast surgery specialist. The Aesthetic Foundation said in a press release she brings “decades of experience in patient-cente
- 2025 AAD: Physosocial Implications of Neuromodulator Injectionshttps://modernaesthetics.com/news/2025-aad-physosocial-implications-of-neuromodulator-injections/2473760/The “Botulinum Toxins: The Latest Updates” session at the 2025 American Academy of Dermatology (AAD) Annual Meeting concluded with Vince Bertucci, MD, FAAD, discussing the topic of “Physosocial Implications of Neuromodulator Injections.” Dr. Bertucci explained the facial feedbac
- 2025 AAD: Drs. Shino Bay Aguilera, Michael Somenek Face Off Over Filler Treatmentshttps://modernaesthetics.com/news/2025-aad-drs-shino-bay-aguilera-michael-somenek-face-off-over-filler-treatments/2473759/A ticketed session at the 2025 American Academy of Dermatology (AAD) Annual Meeting brought together leading experts in the field to debate some of the hottest injectable controversies from an evidence-based perspective, helping attendees choose the most appropriate treatments and achieve natural
- 2025 AAD Meeting: Innovations for Treatment of Burn and Trauma Scarshttps://modernaesthetics.com/news/2025-aad-meeting-innovations-for-treatment-of-burn-and-trauma-scars/2473755/The use of lasers and energy-based device technology to treat different types of scars continues to evolve. Arielle N.B. Kauvar, MD, FAAD; Kristen Marie Kelly, MD, FAAD; Girish S. Munavalli, MD, MHS, FAAD; and Jill Waibel, MD, FAAD, explored the traditional and cutting-edge techniques for correct
- 2025 AAD: New Technologies for Face and Body Treatmentshttps://modernaesthetics.com/news/2025-aad-new-technologies-for-face-and-body-treatments-1/2473754/Skin tightening, innovations for cellulite and contouring, muscle stimulation methods, and hair restoration technology were the topics of “New Technologies for the Face and Body” presented by Neil Sadick, MD, FACP, FAACS, FACPh, FAAD, during the “Future of Cosmetic Dermatology” session at the 202
- Research Letter: Molecule Enhances Skin Barrier, Reduces Retinoid Side Effectshttps://modernaesthetics.com/news/research-letter-molecule-enhances-skin-barrier-reduces-retinoid-side-effects/2473752/A formulation containing Epicutis Skincare’s proprietary TSC molecule significantly reduced erythema and dryness caused by tretinoin, according to a research letter published in the Journal of Cosmetic Dermatology. The